跳至主要内容
临床试验/NCT04786782
NCT04786782进行中(未招募)不适用

Clinical Management of Patients With Cirrhotic Portal Hypertension Based on the Noninvasive Portal Pressure Gradient (vPPG) Detecting Software, a Prospective and Controlled Cohort Study

Changqing Yang1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2021年3月3日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
250
试验地点
1
主要终点
The morbidity of cirrhotic decompensated events

研究概览

简要总结

The aim of this study is to investigate the possibilities and effectiveness of managing cirrhotic portal hypertension using the non-invasive portal pressure gradient (PPG) detecting software. In this study, the three-dimensional reconstruction and natural follow-up methods have been respectively applied in the experimental (1st) and active comparator (2nd) group. The virtual PPG is calculated with anatomical and hemodynamic information of portal system collected by ultrasound and CT tests. Cirrhosis patients in the 1st group, with calculated vPPG values, are managed with upper GI endoscopic results. Besides, patients in the 2nd group, are managed according to the most updated Chinese clinical guideline for cirrhotic portal hypertension, namely, patients with either liver stiffness measurement (LSM) >15kPa or PLT count <150*10^9 should be screened and treated with upper GI endoscopy. The morbidity of decompensated cirrhotic events and mortality of patients in two arms will be compared. The cutoff values of vPPG to spare endoscopies with low missed VNT (varices needing treatment) are preliminarily determined with the cohort data.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inpatients (Shanghai Tongji Hospital) with cirrhosis, which is confirmed by the imaging tests (upper abdominal ultrasound/CT/MRI) or liver biopsy pathology.

排除标准

  • Portal vein embolism;
  • Splenectomy;
  • Hepatic encephalopathy;
  • Hepatic space occupying lesions (such as hepatic cysts, hemangiomas, etc.) with diameter > 3cm and local compression effect;
  • Contraindications of enhanced CT test, such as iodine allergy, peripheral veins are too thin to inject contrast medium;
  • Contraindications of upper GI endoscopy

结局指标

主要结局

The morbidity of cirrhotic decompensated events

时间窗: 2 years

The occurence rate of cirrhotic decompensated events of enrolled patients

The mortality of cirrhosis

时间窗: 2 years

Patients who die because of cirrhosis

次要结局

  • Spared endoscopies(2 years)
  • Number of missed VNT(2 years)

研究者

发起方
Changqing Yang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Changqing Yang

Principal Investigator,Head of Gastroenterology and Hepatology, Chief Physician, Professor

Shanghai Tongji Hospital, Tongji University School of Medicine

研究点 (1)

Loading locations...

相似试验